Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
Grace Lai-Hung Wong
Clin Mol Hepatol. 2018;24(2):108-113.   Published online 2018 Jan 22     DOI:
Citations to this article as recorded by Crossref logo
Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
Hye Won Lee, Seung Up Kim, Baatarkhuu Oidov, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Scientific Reports.2019;[Epub]     CrossRef
Updated Treatment of Chronic Hepatitis B
Eileen L. Yoon, Hyung Joon Yim
The Korean Journal of Medicine.2019; 94(3): 252.     CrossRef
Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8+ T Cells in Patients Considered Immune Tolerant
Pil Soo Sung, Dong Jun Park, Jung-Hee Kim, Ji Won Han, Eun Byul Lee, Gil Won Lee, Hee Chul Nam, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Eui-Cheol Shin, Su-Hyung Park, Seung Kew Yoon
Frontiers in Immunology.2019;[Epub]     CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2019; 25(2): 93.     CrossRef